Cargando…

Diabetic Retinopathy and Skin Tissue Advanced Glycation End Products Are Biomarkers of Cardiovascular Events in Type 2 Diabetic Patients

Risk of cardiovascular events is not homogeneous in subjects with type 2 diabetes; therefore, its early identification remains a challenge to be met. The aim of this study is to evaluate whether the presence of diabetic retinopathy and accumulation of advanced glycation end-products in subcutaneous...

Descripción completa

Detalles Bibliográficos
Autores principales:	Planas, Alejandra, Simó-Servat, Olga, Hernández, Cristina, Ortiz-Zúñiga, Ángel, Marsal, Joan Ramón, Herance, José R., Ferreira-González, Ignacio, Simó, Rafael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8707336/ https://www.ncbi.nlm.nih.gov/pubmed/34945815 http://dx.doi.org/10.3390/jpm11121344

Ejemplares similares

Advanced Glycations End Products in the Skin as Biomarkers of Cardiovascular Risk in Type 2 Diabetes
por: Planas, Alejandra, et al.
Publicado: (2022)

Genetics in Diabetic Retinopathy: Current Concepts and New Insights
por: Simó-Servat, Olga, et al.
Publicado: (2013)

Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on Physiopathology
por: Simó-Servat, Olga, et al.
Publicado: (2016)

Usefulness of the Vitreous Fluid Analysis in the Translational Research of Diabetic Retinopathy
por: Simó-Servat, Olga, et al.
Publicado: (2012)

Neurovascular Unit: A New Target for Treating Early Stages of Diabetic Retinopathy
por: Simó, Rafael, et al.
Publicado: (2021)

Usefulness of Eye Fixation Assessment for Identifying Type 2 Diabetic Subjects at Risk of Dementia
por: Simó-Servat, Olga, et al.
Publicado: (2019)

Diabetic retinopathy as an independent predictor of subclinical cardiovascular disease: baseline results of the PRECISED study
por: Simó, Rafael, et al.
Publicado: (2019)

Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy
por: Vilsbøll, Tina, et al.
Publicado: (2018)

Phenotyping Type 2 Diabetes in Terms of Myocardial Insulin Resistance and Its Potential Cardiovascular Consequences: A New Strategy Based on (18)F-FDG PET/CT
por: Herance, José Raul, et al.
Publicado: (2022)

Efficacy of Insulin Titration Driven by SMS in Improving Glycemic Control in People with Type 2 Diabetes
por: Ortiz-Zúñiga, Ángel, et al.
Publicado: (2023)

Inflammation: The Link between Neural and Vascular Impairment in the Diabetic Retina and Therapeutic Implications
por: Ramos, Hugo, et al.
Publicado: (2023)

New Insights into the Mechanisms of Action of Topical Administration of GLP-1 in an Experimental Model of Diabetic Retinopathy
por: Sampedro, Joel, et al.
Publicado: (2019)

The Gaze Fixation Assessed by Microperimetry: A Useful Tool for the Monitoring of the Cognitive Function in Patients with Type 2 Diabetes
por: Ortiz-Zúñiga, Ángel Michael, et al.
Publicado: (2021)

State-of-the-Art Research on Diabetic Retinopathy
por: Simó, Rafael
Publicado: (2022)

Advances in the Medical Treatment of Diabetic Retinopathy
por: Simó, Rafael, et al.
Publicado: (2009)

Proteomic Analysis of Early Diabetic Retinopathy Reveals Mediators of Neurodegenerative Brain Diseases
por: Sundstrom, Jeffrey M., et al.
Publicado: (2018)

Effects of the Topical Administration of Semaglutide on Retinal Neuroinflammation and Vascular Leakage in Experimental Diabetes
por: Simó, Rafael, et al.
Publicado: (2021)

Insights into Insulin Resistance and Calcification in the Myocardium in Type 2 Diabetes: A Coronary Artery Analysis
por: Martín-Saladich, Queralt, et al.
Publicado: (2023)

Genetic Testing to Predict Weight Loss and Diabetes Remission and Long-Term Sustainability after Bariatric Surgery: A Pilot Study
por: Ciudin, Andreea, et al.
Publicado: (2019)

Advanced glycation end products in diabetic retinopathy and phytochemical therapy
por: Kang, Qingzheng, et al.
Publicado: (2022)

New Insights into Treating Early and Advanced Stage Diabetic Retinopathy
por: Simó, Rafael, et al.
Publicado: (2022)

What else can we do to prevent diabetic retinopathy?
por: Simó, Rafael, et al.
Publicado: (2023)

Retinal Microperimetry: A Useful Tool for Detecting Insulin Resistance-Related Cognitive Impairment in Morbid Obesity
por: Ciudin, Andreea, et al.
Publicado: (2019)

Effect of Topical Administration of Somatostatin on Retinal Inflammation and Neurodegeneration in an Experimental Model of Diabetes
por: Hernández, Cristina, et al.
Publicado: (2020)

Neurodegeneration in diabetic retinopathy: does it really matter?
por: Simó, Rafael, et al.
Publicado: (2018)

Evaluation of Relevance between Advanced Glycation End Products and Diabetic Retinopathy Stages Using Skin Autofluorescence
por: Takayanagi, Yuji, et al.
Publicado: (2020)

Usefulness of Liquid Biopsy Biomarkers from Aqueous Humor in Predicting Anti-VEGF Response in Diabetic Macular Edema: Results of a Pilot Study
por: Udaondo, Patricia, et al.
Publicado: (2019)

Neuroprotection as a Therapeutic Target for Diabetic Retinopathy
por: Hernández, Cristina, et al.
Publicado: (2016)

Effects of Liposomal Formulation of Citicoline in Experimental Diabetes-Induced Retinal Neurodegeneration
por: Bogdanov, Patricia, et al.
Publicado: (2018)

Retinal sensitivity and gaze fixation evaluated by microperimetry in subjects with type 2 diabetes: two independent parameters that explore different neuronal circuits
por: Ortiz-Zuñiga, A. M., et al.
Publicado: (2023)

Iron Overload in Diabetic Retinopathy: A Cause or a Consequence of Impaired Mechanisms?
por: Ciudin, Andreea, et al.
Publicado: (2010)

Berberine suppresses advanced glycation end products‐associated diabetic retinopathy in hyperglycemic mice
por: Wang, Ning, et al.
Publicado: (2021)

Diabetic retinopathy as a predictor of cardiovascular morbidity and mortality in subjects with type 2 diabetes
por: Barrot, Joan, et al.
Publicado: (2022)

Mechanisms of retinal neuroprotection of calcium dobesilate: therapeutic implications
por: Simó-Servat, Olga, et al.
Publicado: (2017)

Inhibition of Receptor for Advanced Glycation End Products as New Promising Strategy Treatment in Diabetic Retinopathy
por: Saleh, Irsan, et al.
Publicado: (2019)

Topical Administration of Bosentan Prevents Retinal Neurodegeneration in Experimental Diabetes
por: Bogdanov, Patricia, et al.
Publicado: (2018)

The Correlation between the Level of Skin Advanced Glycation End Products in Type 2 Diabetes Mellitus and the Stages of Diabetic Retinopathy and the Types of Traditional Chinese Medicine Syndrome
por: Zhang, Senwei, et al.
Publicado: (2022)

Proapoptotic and survival signaling in the neuroretina at early stages of diabetic retinopathy
por: Valverde, Angela M., et al.
Publicado: (2013)

The Footprint of Type 1 Diabetes on Red Blood Cells: A Metabolomic and Lipidomic Study
por: Herance, José Raul, et al.
Publicado: (2023)

Neuromodulation Induced by Sitagliptin: A New Strategy for Treating Diabetic Retinopathy
por: Ramos, Hugo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rpo2r5e4qulg40egrhsd15a1an